Publications on Cancer Adjuvants & TLR Heteroagonists

Explore innovative strategies that harness toll-like receptor (TLR) biology to improve cancer immunotherapy. These publications focus on adjuvants and heteroagonists that activate multiple TLR pathways, aiming to boost anti-tumor immune responses and improve the precision and potency of cancer treatments.